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ABSTRACT
Notch signaling regulates a multitude of cellular processes. During
ocular lens development this pathway is required for lens progenitor
growth, differentiation and maintenance of the transition zone. After
ligand-receptor binding, the receptor proteins are processed, first by
ADAM proteases, then by γ-secretase cleavage. This results in the
release of a Notch intracellular domain (N-ICD), which is recruited into
a nuclear transcription factor complex that activates Notch target
genes. Previous in vitro studies showed that the Delta-like and
Jagged ligand proteins can also be cleaved by the γ-secretase
complex, but it remains unknown whether such processing occurs
during in vivo vertebrate development. Here we show that mouse and
human lens progenitor cells endogenously express multiple Jagged1
protein isoforms, including a Jagged1 intracellular domain. We also
found that pharmacologic blockage of γ-secretase activity in vitro
resulted in an accumulation of Jagged1 polypeptide intermediates.
Finally, overexpression of an epitope-tagged Jagged1 intracellular
domain displayed nuclear localization and induced the upregulation
of endogenous JAG1 mRNA expression. These findings support the
idea that along with its classical role as a Notch pathway ligand,
Jagged1 is regulated post-translationally, to produce multiple active
protein isoforms.
KEY WORDS: Jagged1, Notch signaling, Presenilin, Gamma
secretase (γ-secretase), ADAM protease, Lens development
INTRODUCTION
The Notch signaling pathway is highly conserved among metazoans
and functions in a variety of cellular activities, including cell fate
determination. One developing tissue that relies on Notch signaling
is the ocular lens. The vertebrate lens consists of anterior epithelial
progenitor cells that terminally differentiate into organelle-free fiber
cells. This is an attractive tissue for studying complex cell–cell
signaling pathways, given its simple architecture and dispensability.
Vertebrate lens induction initiates at E9.0 in the mouse when the
surface ectoderm thickens into a lens placode (Charlton-Perkins
et al., 2011; Piatigorsky, 1981). Lens placode formation relies on
signals from the underlying optic vesicle, a neuroepithelium
extension of the ventral forebrain that gives rise to both the neural
retina and retinal pigment epithelium (Fuhrmann, 2010). At E10.5,
the lens placode invaginates into a lens pit, which subsequently
detaches from the surface ectoderm as a hollow lens vesicle,
comprised entirely of progenitor cells (McAvoy et al., 1999). Then
posterior progenitor cells, those closest to the developing retina,
elongate as they differentiate into primary lens fiber cells. At the
same time, anterior progenitor cells coalesce into the anterior
epithelial layer (AEL). At E14.5, the lens switches its mode of
development, when AEL cells begin to migrate to the equatorial
transition zone, which constitutes a boundary between progenitors
and differentiated fiber cells (reviewed in Mochizuki and Masai,
2014). Upon terminal differentiation, secondary fiber cells surround
the primary fiber cells that comprise the central core of the lens.
Previous studies demonstrated that Notch signaling regulates
progenitor cell proliferation, secondary fiber cell differentiation
and helps maintain the transition zone (Azimi et al., 2018; Jia et al.,
2007; Le et al., 2009; Rowan et al., 2008; Saravanamuthu et al.,
2009).
After ligand binding, Notch receptors undergo proteolysis, to
release the Notch intracellular domain (N-ICD) polypeptide
fragment (Bray, 2006; Schroeter et al., 1998). There are two
broad classes of Notch ligands, Delta or Delta-like (Dll) and Serrate/
Jagged (Jag), with mammalian genomes containing multiple
paralogs for each type of ligand. Ligand truncations lacking either
the extracellular or intracellular domain, fail to trigger Notch
receptor activation, demonstrating that the entire ligand protein is
necessary for functionality (Shimizu et al., 1999; Sun and
Artavanis-Tsakonas, 1996). After receptor–ligand interaction, the
Notch receptor is sequentially cleaved, with each event mediated by
different enzymatic activities (reviewed in Kopan and Ilagan, 2009).
First, ADAM proteases remove the Notch receptor extracellular
domain, followed by γ-secretase protein complex cleavage within
the transmembrane region, to release the N-ICD from the plasma
membrane (Struhl and Greenwald, 1999). The γ-secretase complex
is comprised of four proteins: Nicastrin, Aph-1, Pen2, and
Presenilin (Psen), with Psen exhibiting the catalytic activity.
Moreover, the γ-secretase complex cannot cleave full length
Notch receptors, likely due to steric hindrance from the receptor
extracellular domain. Thus, ADAM protease activity is a
prerequisite for N-ICD generation (Bolduc et al., 2016; Struhl and
Adachi, 2000). Once generated, the N-ICD fragment complexes
with Rbpj andMastermind proteins, which transcriptionally activate
downstream genes within the nucleus (Wilson and Kovall, 2006).
In addition to Notch receptors, the γ-secretase complex cleaves at
least 90 other substrates, including the amyloid precursor protein
(APP), which accumulates abnormally in Alzheimer’s disease (Beel
and Sanders, 2008; Haapasalo and Kovacs, 2011). Interestingly,
previous in vitro studies showed that both Dll and Jag ligands can
also be cleaved by γ-secretase (Ikeuchi and Sisodia, 2003; LaVoie
and Selkoe, 2003; Six et al., 2003), and that overexpression of full
length Dll or Jag in cultured cells facilitated the appearance of
ligand-CTF isoforms, lacking extracellular ligand domains. This is
consistent with the idea that ADAM proteases can cleave some of
the Notch ligands. Furthermore, CTF isoforms accumulated
after cells were treated with γ-secretase inhibitors, suggesting they
are γ-secretase substrates. Although these data strongly suggestReceived 18 December 2018; Accepted 28 February 2019
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Notch pathway ligands as ADAM and/or γ-secretase substrates, the
physiological relevance of ligand processing during development,
homeostasis, or pathogenesis are essentially unknown. One
recent in vivo study highlighted a role for the Jag1 intracellular
domain (J1-ICD) in mouse adult cardiomyocytes (Metrich et al.,
2015). Here J1-ICD overexpression reduced both Notch1
processing (N1-ICD levels), and the expression of downstream
target genes Hes1 and Hey1/2. Moreover, increased J1-ICD
expression correlated with reduced proliferation and premature
cardiomyocyte differentiation. Therefore, Notch ligand processing
may modulate signaling levels, via ligand turnover from the cell
membrane and/or ligand intracellular domains could have intrinsic
signaling activity.
Given that Notch receptor protein processing has been
extensively studied and there remains sustained interest in
pharmacologic interventions to block Notch dysregulation, deeper
understanding of ligand protein regulation seems warranted. Here
we show the presence of Jag1 protein isoforms during in vivomouse
lens development and test whether ADAM protease and γ-secretase
activities regulate this ligand in vitro, using a human lens epithelial
cell line. Moreover, mouse Jag1 colocalizes with Psen1 at three key
ages of lens formation, consistent with the idea that γ-secretase can
also cleave this ligand. We also describe multiple Jag1 protein
isoforms in other developing mouse tissues, whose sizes correspond
to full length Jag1, a Jag1-CTF intermediate, and the intracellular
domain, J1-ICD. We found that human lens B3 cells endogenously
express and process JAG1 protein, as well as transfected, epitope-
tagged Jag1 isoforms that localized to the expected subcellular
compartments. We also treated lens B3 cells with DAPT, which
induced the accumulation of endogenous JAG1-CTF, the predicted
γ-secretase substrate. Finally, J1-ICD overexpression in B3 cells
stimulated an upregulation of endogenous JAG1mRNA, suggesting
that JAG1 protein isoforms can participate in Notch pathway
feedback regulation.
RESULTS
Multiple Jag1 protein isoforms are present during mouse
embryogenesis
Previous in vitro work demonstrated that epitope-tagged rat Delta-
like (Dll) and Jagged1 (Jag1) proteins are cleaved by the γ-secretase
complex (LaVoie and Selkoe, 2003). Given that the removal of Jag1
activity during mouse lens development results in postnatal lens
aphakia (Le et al., 2009), we hypothesized that post-translational
processing of this ligand may be one mechanism for regulating its
activity during embryogenesis. If the Jag1 ligand protein is
processed analogously to Notch receptors, we would expect to see
three distinct isoforms: full length Jag1 (FL-Jag1), Jag1 C-terminal
fragment (Jag1-CTF) and Jag1 intracellular domain (J1-ICD). An
ADAM-mediated juxtamembrane cleavage of FL-Jag1 removes the
larger extracellular region (ectodomain) of the protein, resulting in
the Jag1-CTF isoform. According to one study, ADAM17 activity
is associated with Jag1 ectodomain shedding, while ADAM10 is
responsible for Delta processing (LaVoie and Selkoe, 2003). After
ectodomain removal, the Jag1-CTF intermediate is primed for a
second cleavage within the transmembrane domain, by the
γ-secretase complex, to produce the J1-ICD isoform. This Jag1
intracellular fragment, like an N-ICD, would no longer be tethered
to the plasma membrane and free to translocate elsewhere inside the
cell. Therefore, we used predicted cleavage site consensus
sequences to estimate the molecular weights for each isoform
(Fig. 1A). In mouse, FL-Jag1 is 134 kDa, the Jag1-CTF would be
24 kDa, while the J1-ICD isoform is predicted to be 14 kDa.
To determine if FL-Jag1 undergoes either type of proteolytic
cleavage in vivo, we collected several different developing mouse
tissues in which the Jag1 ligand is a key component of Notch
signaling, and analyzed total protein lysates by western blotting,
using a C-terminal specific Jag1 antibody (Le et al., 2009). This
antibody should detect all predicted Jag1 isoforms since each retains
an intact C-terminus, yet allow for identification of each proteolytic
product by its distinct molecular weight. We probed E9.5 whole
mouse embryo extracts, a developmental age when there is very
high Notch activity throughout the body. We detected both FL-Jag1
and a fragment matching the predicted size of the J1-ICD (Fig. 1B).
Longer exposure times did reveal the Jag1-CTF band in whole
embryo total protein extracts (data not shown). By contrast, in both
the E14.5 and E16.5 lens, all three predicted Jag1 isoforms were
readily visualized (Fig. 1C,D). Conversely, in other tissues, only the
lower molecular weight Jag1 protein isoforms were detected. For
instance, the Jag1-CTF and J1-ICD were abundant in E14.5 liver
and E16.5 heart tissue lysates (Fig. 1E,F). We also consistently
noted a protein doublet for the Jag1-CTF, suggesting the possibility
of two potential cleavage start sites, or that this protein undergoes
additional post-translational modifications. Intriguingly, each band
in the doublet displayed different signal strengths, depending on the
tissue analyzed. We also performed another western blot with all
embryonic tissue lysates present on single blot and then reprobed it
with a β-actin antibody, for direct comparison of protein loading
(Fig. S1).
Because the Jag1-CTF was consistently present in embryonic
lens extracts, we wished to understand if production of this isoform
depends on the activity of particular Adam proteins. Although there
are 40 different Adam genes in mammalian genomes, two family
members have consistently been associated with the Notch
signaling pathway, Adam10 and Adam17 (Groot and Vooijs,
2012). Interestingly, the Drosophila Adam10 homolog,
Kuzbanian, cleaves the Delta ligand in fly embryos (Qi et al.,
1999). Therefore, we compared Jag1 protein isoforms in the absence
of Adam10 or Adam17, by western blotting of total protein extracts
from E14.5 mouse lenses collected from control and mutants
(Fig. S2). Conditionally mutant lens tissues were generated using
the same Cre-lox strategy employed in previous studies of Notch
signaling in the developing mammalian lens (Azimi et al., 2018;
Le et al., 2009; Rowan et al., 2008), by using Le-Cre to delete either
Adam10 or Adam17, producing heterozygotes and homozygotes in
normal Mendelian ratios. We noted comparable levels of Jag1-CTF
in E14.5 control, Le-Cre;Adam17CKO/+ and Le-Cre;Adam17CKO/CKO
lanes (Fig. S2A), suggesting that Adam17 does not cleave Jag1.
However, lens extracts from E14.5 Le-Cre;Adam10CKO/CKOmutants
completely lacked Jag1-CTF protein (Fig. S2B). By comparison,
Notch2 receptor protein processing was also affected in Le-Cre;
Adam10CKO/CKO mutants, where there was reduced levels of the
Notch2 extracellular truncation fragment (N2-EXT), which is
normally generated by Adam cleavage (Fig. S2C). These data
suggest that Adam10 cleaves both Notch2 and Jag1 proteins in the
embryonic mouse lens.
Jag1 and Psen1 protein co-expression during lens
development
In mammals, there are two Psen genes, Psen1 and Psen2, that are
both present in the developing mouse lens (Azimi et al., 2018),
although each γ-secretase protein complex only contains one Psen
protein paralog (De Strooper et al., 2012). In many tissues there
are different requirements for Psen1- versus Psen2-containing
γ-secretase complexes, best illustrated by the early lethality ofPsen1
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germline mutants, whereas Psen2 mutants are adult viable
(Donoviel et al., 1999; Shen et al., 1997). Although both Psen
proteins catalyze proteolysis, Psen1 and Psen2 display different
substrate specificities that are linked to distinct intracellular
localizations (Sannerud et al., 2016). The Psen1 protein is more
highly expressed at the plasma membrane, whereas Psen2 is largely
found in the membranes of late endosomes and lysosomes. Thus,
it is not surprising that Psen1-containing γ-secretase complexes
are more efficient at cleaving the plasma membrane protein Cdh2/
N-Cadherin than those complexes containing the Psen2 protein
(Sannerud et al., 2016).
Since the Jag1 protein has transmembrane domains and localizes
to the cell membrane (Grochowski et al., 2016), we wished to
compare its expression pattern to that of Psen1, using previously
validated specific antibodies (Azimi et al., 2018). If Psen1-
containing γ-secretase complexes cleave the Jag1-CTF to produce
a J1-ICD fragment, then Jag1 and Psen1 should colocalize. We
performed double antibody labeling at different lens developmental
ages, ranging from E11.5 to E16.5. At E11.5, Psen1 and
Jag1 expression overlapped in posterior lens progenitor cells as
they initiate primary fibergenesis (Fig. 2A–A″). However, once
secondary fibergenesis begins at E14.5 and onwards, Psen1 and
Jag1 were both observed in the transition zone within nascent,
secondary fiber cells (Fig. 2C–C″,E–E″). Thus, Psen1 and Jag1
coexpression further supports our idea that during in vivo lens
formation Jag1 appears to be a γ-secretase substrate.
Endogenous JAG1 protein processing in a human lens
epithelial cell line
Given the relatively low level of J1-ICD protein detectable in protein
extracts from 12 pooled mouse E14.5 lenses, we took advantage
of a well-characterized human lens epithelial cell line (HLE-B3,
termed B3 here) (Andley et al., 1994) to analyze JAG1 protein
post-translational processingmore deeply. These cells endogenously
express the relevant Notch signaling pathway components (Fig. 3A).
We also detected endogenously processed NOTCH2 receptor
protein (N2), with the N2-ICD isoform being abundant in B3 cell
protein extracts. By comparison, human B3 cells endogenously
express the J1-ICD isoform at relatively low levels, similar to mouse
embryonic lenses (Fig. 3A–C, and data not shown). The lower levels
of J1-ICD in both B3 cells and prenatal mouse lenses might be
attributed to a short half-life for this isoform, and/or it may undergo
Fig. 1. Survey of mouse Jagged1 protein
isoforms in multiple embryonic tissues.
(A) Schematic of Jag1 processed isoforms
and predicted molecular weights. Red and
purple symbols represent the presumed
cleavages by ADAM (red) or γ-secretase
(purple) activities. (B–F) Western blot
analysis using a C-terminal specific Jag1
antibodies that recognizes all protein
isoforms in rodent and human cells.
(B) Whole E9.5 mouse embryo extract
containing FL-Jag1, Jag1-CTF (seen in
longer exposure), and J1-ICD, using goat
anti-Jag1 antibody. All three Jag1 isoforms
are also detected in the developing lens at
(C) E14.5 and (D) E16.5. The only
detectable isoforms in (E) E14.5 liver and
(F) E16.5 heart tissues are the Jag1-CTF
and J1-ICD. Panels C–F were generated
using rabbit anti-Jag1 antibody. All blots are
representative of three independent protein
preparations and western blots (biological
replicates).
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further processing, such that it escapes detection with a C-terminal
antibody. To test the first idea, B3 cells were treated
with epoxomicin, a potent proteasome inhibitor (Meng et al.,
1999) for 24 h, across a fourfold concentration range and the cell
lysates assayed by western blot for the presence of different JAG1
isoforms (Fig. 3B). Although the epoxomicin treatment did not
enhance our visualization of the J1-ICD, we did see an increase of
JAG1-CTF expression in treated cells. This implies that in the
mammalian lens, the Jag1-CTF isoformmay normally be turned over
via proteasomal degradation.
Next, we wished to test for γ-secretase complex activity in B3
cells by treating them with N-[N-(3,5-difluorophenacetyl)-L-
alanyl]-S-phenylglycine t-butyl ester (DAPT), which binds to the
C-terminus of Psen proteins and effectively blocks Notch receptor
intracellular domain production (Dovey et al., 2001; Geling et al.,
2002; Morohashi et al., 2006). Thus, by analogy, administration of
the γ-secretase inhibitor DAPT in B3 cells should block J1-ICD
production. However, since consistent visualization of the
endogenous J1-ICD isoform is challenging, we instead asked
whether DAPT-treated B3 cells accumulate more JAG1-CTF, the
Fig. 2. Jag1 and Psen1 co-localization in the
prenatal mouse lens. Double antibody labelling of
wild-type E11.5 lens cryosections (A–A″)
demonstrating that Psen1, being ubiquitously
expressed in the developing lens (Azimi et al.,
2018), has overlap with the Jag1 protein domain
(visualized using goat anti-Jag1) that marks the
posterior half of the lens vesicle, where cells are
beginning to differentiate into primary fiber cells.
At E14.5 (B–B″) and E16.5 (D–D″) Jag1 and
Psen1 colocalization becomes confined to the
Jag1-expressing domain that is now restricted at
the lens transition zone, seen more clearly in
close-up images (C–C″) and (E–E″), respectively.
n=4 biological replicates at E11.5 and E14.5; n=2
biological replicates at E16.5. Anterior is up in all
panels. LV, lens vesicle; L, lens; R, retina. Scale
bar: in A,C,E = 50 µm, in B,D = 100 µm.
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presumed substrate of the γ-secretase complex (Fig. 3C). We noted
an accumulation of the JAG1-CTF, similar to previous in vitro
assessments of JAG1 protein processing (LaVoie and Selkoe, 2003;
Metrich et al., 2015). To independently demonstrate the ability of
B3 cells to produce JAG1 protein isoforms, we transfected B3 cells
with three different constructs containing HA epitope-tagged forms
of rat FL-Jag1, Jag1-CTF, and J1-ICD (LaVoie and Selkoe, 2003),
which each electrophorese at slightly higher molecular weights than
Fig. 3. See next page for legend.
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their endogenous counterparts. We used both specific Jag1
antibodies and an anti-HA antibody to detect the tagged isoforms
(Fig. 3D; Fig. S3). Interestingly, cell lysates from both FL-Jag1-HA
and Jag1-CTF-HA transfection contained the J1-ICD isoform
(Fig. 3D, compare with J1-ICD-HA transfected lane).
Paradoxically, the anti-HA antibody probed western blot also
detected the epitope-tagged J1-ICD in lysates from in Jag1-CTF-
HA transfection, but, not in the FL-Jag1-HA transfected lysates
(Fig. S3). This might suggest that the J1-ICD band we observe
with the anti-Jag1 antibody upon transfection with FL-Jag1-HA
(Fig. 3D) stems from endogenous protein in the cell being
preferentially processed into J1-ICD. It could be that the HA-tag
on the FL-Jag1-HA protein sterically hinders the γ-secretase
complex from binding and/or cleaving this isoform, thereby
allowing it to only act on the endogenous Jag1 protein inside the
cell to generate untagged J1-ICD. Alternatively the HA-tag may be
selectively cleaved off of only the FL-Jag1-HA by an unknown
mechanism.
We then used DAPT to block γ-secretase activity and ask to what
extent this affected the relative expression of the different tagged
Jag1 isoforms, via western blotting of cell protein lysates. We found
that DAPT-mediated inhibition of γ-secretase in B3 cells transfected
with the FL-Jag1-HA resulted in an accumulation of both Jag1-
CTF-HA and J1-ICD-HA isoforms (Fig. 3E). Because Jag1-CTF is
the presumed substrate of γ-secretase activity, accumulation of this
tagged isoform after DAPT treatment (Fig. 3E) is consistent with an
increase in endogenous JAG1-CTF in non-transfected cells
(Fig. 3C). However, we anticipated that J1-ICD expression would
be missing. Nonetheless, we observed that DAPT treatment
following Jag1-CTF-HA transfection resulted in more JAG1-CTF
and a loss of the J1-ICD band (Fig. 3E).
Subcellular localization of epitope-tagged Jag1 proteins
isoforms in B3 cells
Intramembrane cleavage by γ-secretase releases the N-ICD
fragment from the plasma membrane, facilitating its accumulation
in a nuclear protein complex that regulates the transcription of target
genes. Using B3 cells transfected with epitope-tagged Jag1
constructs, we compared the subcellular localization of the
FL, CTF and ICD Jag1 isoforms. Similar to the Notch receptor
N-ICD fragment, the J1-ICD polypeptide contains a nuclear
localization signal that is conserved from Drosophila Serrate to
human JAG1 and JAG2 proteins. Using specific antibodies for
either the HA-epitope tag (green) or the Jag1 C-terminus (red),
we co-immunolabeled the transfected B3 cells. As a control,
Fig. 3. DAPT-treatment of human lens B3 cells induces changes in
endogenous JAG1 protein processing. (A) Endogenous JAG1, NOTCH2
and PSEN1 expression in B3 cell lysates. Each lane/strip blot contains 50 µg
of B3 cell total protein that was separately probed with rabbit anti-Jag1,
rabbit anti-Psen1 (N-terminus), or rat anti-Notch2 to reveal expression of
FL-JAG1, PSEN1 and NOTCH2 proteins. The JAG1-CTF isoform was
observable in longer exposures (not shown, see control lanes in Fig. 3B,C).
The NOTCH2 full length and N2-ICD isoforms were clearly detectable.
(B–C) B3 cells treated with different concentrations of Epoxomicin versus
DMSO (B), or 10 µM DAPT versus DMSO (C) for 24 h and cell lysates
analyzed for JAG1 protein isoforms via western blot using rabbit anti-Jag1
antibody. (D) Western blotting of B3 cells transfected with C-terminal HA-
tagged isoforms of rat Jag1 protein (50 µg total protein loaded per lane; blot
probed with rabbit anti-Jag1 antibody). (E) B3 cells transfected with either
FL-Jag1-HA of Jag1-CTF-HA constructs, followed by treatment with 10 µM
DAPT (versus DMSO alone) for 24 h. Western blot probed with rabbit anti-
Jag1. In all panels, blots were reprobed with mouse anti β-Actin as a loading
control. Each blot is representative of n=3 independent biological replicates.
Fig. 4. Different subcellular localizations of
transfected epitope-tagged Jag1 constructs. In
transfected B3 lens progenitor cells co-labeled with
rabbit anti-HA (green) and goat anti-Jag1 (red)
antibodies, FL-Jag1-HA is present throughout the cell
but excluded from nucleus (A–A″). The distribution of
Jag1-CTF-HA is similar to the full length tagged
protein except also uniquely displays some nuclear
localization (B–B″). J1-ICD-HA transfected cells
exhibit strong nuclear expression (C–C″). n=3
biological replicate experiments for each construct.
Scale bar: 50 µm.
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non-transfected B3 cells did not label with the anti-HA-antibody,
while the anti-Jag1 antibody faintly labeled the plasma membrane
(data not shown). We also confirmed that there was no cross-
reactivity among the secondary antibody reagents by omitting the
relevant primary reagent in replicate experiments (not shown). Cells
transfected with the FL-Jag1-HA construct showed labeling by both
antibodies throughout the cell cytoplasm and at the cell surface,
(Fig. 4A–A″). Those cells transfected with Jag1-CTF-HA displayed
a similar labeling pattern to those with FL-Jag-HA, but with some
unique expression within the DAPI-labeled (blue) nuclei (Fig. 4B–
B″). Interestingly J1-ICD-HA transfected cell nuclei were more
obviously labeled by both antibodies (Fig. 4C–C″). Based on our
observation that Jag1-CTF-HA transfection appears to enhance the
accumulation of exogenous J1-ICD (Fig. 3D), it is possible that the
additional nuclear expression in Jag1-CTF-HA transfected cells is
attributable to enhanced production of J1-ICD (both endogenous
and epitope-tagged) in these cells. Overall, we conclude that the
J1-ICD isoform is capable of localizing in B3 nuclei.
J1-ICD-HA protein overexpression induces endogenous
JAG1 transcription
The presence of nuclear J1-ICD protein raises the possibility that it
might induce a cellular response, and so represent an alternative
mechanism for feedback regulation within the signaling pathway.
Expression of ligand intracellular domain isoforms was previously
implicated in the downregulation of Notch target genes such as
Hes1, Hey1, and Hey2 (Metrich et al., 2015); the activation of
the AP-1 element (LaVoie and Selkoe, 2003); the cellular
transformation of RKE cells (Ascano et al., 2003); an
enhancement of Smad-dependent transcription (Hiratochi et al.,
2007); and an increase Cdh1/E-Cadherin gene expression (Delury
et al., 2013). Here we wished to test the impact of J1-ICD
overexpression on the expression levels of other Notch pathway
genes. We used qRT-PCR to quantify mRNA expression levels
between non-transfected versus J1-ICD-HA-transfected B3 cells.
We also monitored the expression of the ocular factor, PAX6
(Fig. 5). Among the ten genes tested, only JAG1mRNA levels were
significantly affected, showing a fourfold increase. To ensure that
only human B3 cell JAG1 expression was assayed, we used PCR
primers that amplify 5′ sequences not present in the J1-ICD isoform.
Moreover, the J1-ICD-HA construct utilizes rat Jag1 gene
sequences. Overall, our data suggest that Jag1 protein can self-
regulate its own expression, via the activity of a functional J1-ICD
isoform.
DISCUSSION
The objective of this study was to test the hypothesis that the Jag1
ligand protein is cleaved analogously to the Notch receptor during
mammalian lens development, and to explore possible functions
of a J1-ICD polypeptide. Here we demonstrate the expression of
distinct Jag1 protein isoforms, in multiple developing mouse
tissues, including the forming ocular lens. Similar to Notch
receptors, FL-Jag1 undergoes ectodomain shedding, via ADAM
protease activity, to generate a Jag1-CTF intermediate, as well as
γ-secretase complex-mediated intramembrane proteolysis to
produce a J1-ICD polypeptide. We also found that the latter
protein species can be localized to the cell nucleus where it feeds
back onto its own gene transcription.
Previous in vitro studies have also assessed whether ADAM
proteases can cleave Jag1. One study pointed to ADAM17 as
responsible for Jag1-CTF production based on the finding that an
ADAM17-specific inhibitor resulted in lower levels of Jag1-CTF
while an ADAM10-specific inhibitor did not alter Jag1-CTF levels
(LaVoie and Selkoe, 2003). However, another study used siRNA
knockdown to show that ADAM10 is more effective at cleaving
FL-Jag1 than ADAM17 (He et al., 2014). Our in vivo lens
mutant tests, albeit preliminary for ADAM10 mutants, show that in
the developing mouse lens, Jag1-CTF generation is dependent on
ADAM10 and not ADAM17. This is at odds with LaVoie and
Selkoe, who used pharmacologic inhibitors in cultured cells, which
may not have had sufficient specificity for a particular ADAM
protease. Alternatively, the different outcomes could be explained
by cell-type specific activities of individual ADAM proteins.
Our finding that DAPT treatment fails to inhibit J1-ICD
production in B3 cells transfected with FL-Jag1-HA, but not
Jag1-CTF-HA, was puzzling (Fig. 3E). If γ-secretase solely cleaves
Jag1-CTF to produce a J1-ICD, blocking this activity via DAPT
inhibition should prevent the accumulation of the J1-ICD protein.
One possibility may be that Jag1 is so highly over-expressed in the
cell that either the concentration of DAPT or treatment period were
insufficient to effectively block substrate from being processed in
the cell, resulting in some J1-ICD in our extracts. Treating cells with
Fig. 5. Comparison of mRNA expression levels after JICD-HA transfection of B3 cells. The relative mRNA levels of various Notch pathway genes, and
the PAX6 transcription factor, between B3 control versus J1-ICD transfected cells. The relative expression level of each mRNA was determined by qPCR,
normalized to β-actin, and a non-transfected control. The graphed expression values are the mean of three independent biological replicate experiments,
each performed in technical triplicate, with the error bar representing the s.e.m. *P≤0.05. Statistical significance was determined by one-way ANOVA for the
entire dataset, as well as by comparing control and transfected data using a two-tailed Student’s t-test using Microsoft Excel 2016 Analysis ToolPak.
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DAPT either prior or concurrently with transfection might
circumvent Jag1 processing prior to DAPT blockage of
γ-secretase activity. Alternatively, γ-secretase may only act on a
specific Jag1-CTF protein product. Jag1-CTF likely undergoes
other post-translational modifications (or has two possible cleavage
start sites), since it is detected as a protein doublet by western blot.
By referring to the higher molecular weight band as Jag1-CTF-A
and the lower molecular weight band as Jag1-CTF-B, we note that
overexpression of FL-Jag1-HA led to the production of only Jag1-
CTF-A, whereas transfection of the Jag1-CTF-HA construct
produced both Jag1-CTF-A and Jag1-CTF-B, like the in vivo
doublet (Fig. 3D). Moreover, DAPT treatment of the Jag1-CTF-HA
transfected cells resulted in an accumulation of only the Jag1-CTF-
B band (Fig. 3E). It would be interesting in the future to search for
other types of Jag1 protein post-translational modifications, one of
which might produce a preferential substrate for the γ-secretase
complex.
Ligand proteolysis affects the amount of FL-ligand present at the
cell surface. For this reason, this process has been postulated to
modulate Notch signaling levels, by controlling ligand availability
for Notch receptor binding. Our data shows that ligand processing
may also stimulate transcription of ligand mRNA. This finding is at
odds with another study that showed decreased Jag1 mRNA
expression after J1-ICD overexpression in the mouse neonatal heart
(Metrich et al., 2015). One critical difference is that the cardiac
J1-ICD isoform is a 20 kDa fragment, whereas we detected a
14 kDa isoform in the lens. Interestingly, based on protein domains
and amino acid sequence of Jag1, a 20 kDa Jag1 proteolytic
fragment is consistent with an isoform that retains a fully intact
transmembrane domain. Thus, J1-ICD overexpression in cardiac
myocytes might produce a Jag1-CTF that is still membrane-
tethered, unlike the isoforms produced in the lens. It is also possible
that J1-ICD promotes distinct cellular responses in different tissues
or during development (this study) versus in adult tissues (Metrich
et al., 2015). Finally, our finding that overexpressed J1-ICD can
induce endogenous JAG1 mRNA expression might contribute
to ligand recycling since processed proteins are potentially turned
over more rapidly yet simultaneously promote the production of
new ligand.
In the lens, Jag1 activity maintains both AEL progenitor cell
proliferation and secondary fiber cell differentiation in the
equatorial transition zone (Le et al., 2009). Moreover, Le-Cre;
Jag1CKO/CKO mice exhibit more severe adult lens phenotypes than
those of other Notch pathway mutant mice, for example Le-Cre;
RbpjCKO/CKO and Le-Cre;Notch1CKO/CKO;Notch2CKO/CKO mutants
(Azimi et al., 2018; Le et al., 2009; Rowan et al., 2008). Data
presented here are consistent with Jag1 protein regulation post-
translationally via proteolytic processing. This suggests a possible
mechanism by which Jag1 could also act in a Notch-independent
manner to regulate other aspects of lens formation. Interestingly, a
previous study correlated J1-ICD transfection in HEK cells with an
increase in Cdh1 transcription (Delury et al., 2013). Because Jag1
mutant embryonic lenses displayed a severe loss of Cdh1+ AEL
cells (Le et al., 2009), future studies should look more deeply for a
potential relationship between Jag1 protein processing and Cdh1
expression.
It still unknown to what extent Notch ligand ICD polypeptides
can influence gene transcription (directly or indirectly), since the
endogenous levels of this isoform appear to be quite low, at least
during mouse embryogenesis. However, ligand ICD amino acid
sequences contain a PDZ recognition motif that might facilitate
protein–protein interactions (Forghany et al., 2018; Hock et al.,
1998); and this PDZ domain is required during Jag1-mediated
transformation of rat kidney epithelial (RKE) cells, suggesting
ligand ICDs as possessing inherent functionality (Ascano et al.,
2003). It would be informative to search for other proteins that can
physically interact with J1-ICD and perform RNA-seq to quantify
gene expression level changes after J1-ICD overexpression. Deeper
understanding of the potential roles of Jag1 protein isoforms have a




Wild-type CD-1 mice were obtained from Charles Rivers. Le-Cre Tg/+ mice
were maintained on an FVB/N background and PCR genotyped as described
(Ashery-Padan et al., 2000). Adam17tm1.2Bbl mice (Adam17CKO/CKO) were
obtained from the Jackson Laboratory, maintained on a mixed 129-C57BL/6
background and genotyped using JAX online genotyping protocols.
Embryonic mouse lens tissues from Le-Cre;Adam10CKO+/×Adam10CIO/CKO
timed matings were provided and genotyped by Duska Sidjanin (Medical
College of Wisconsin). The embryonic age was determined by vaginal plug
detection at day E0.5.
Ethics statement
All mice were housed and cared for in accordance with guidelines provided
by the National Institutes of Health, Bethesda, Maryland, and the
Association for Research in Vision and Ophthalmology, and conducted
with approval and oversight from the UC Davis Institutional Animal Care
and Use Committees.
Plasmids and transfections
Rat FL-Jag1-HA (pBOS-SN3T), Jag1-CTF-HA (pEF6/V5-His) and JICD-
HA (pEF6/V5-His) HA-tagged expression plasmids were provided by
Matthew LaVoie (LaVoie and Selkoe, 2003) and verified using Sanger
DNA sequencing. Each plasmid was transfected into B3 cells using the
Fugene6 (Promega, Cat#:E2691) protocol at a 3:1 volume ratio of Fugene6
transfection reagent relative to that of the DNA. For immunocytochemistry
experiments, 2.0×105 to 2.5×105 B3 cells were plated per well of a 2-well
chamber slide (Thermo Fisher Scientific, Cat#:177429) and transfected with
40 ng of plasmid after 24 h (∼60–70% confluency). In experiments
generating material for western blot analysis, 1.0×106 to 1.5×106 B3 cells
were plated onto a 100 mm tissue culture plate and transfected with 5 µg
of plasmid after 24 h (60–70% confluency). Cells remained in transfection
mix media for 48 h at 37°C and 5% CO2 before either fixing for
staining protocol or harvesting for protein extraction via cell-scraping in
cold PBS plus cOmplete mini protease inhibitor tablet (Sigma-Aldrich,
Cat#:11836153001), spinning briefly, and snap-freezing the cell pellet.
Cell culture and treatment
The immortalized human epithelial lens cells HLE-B3, termed B3 here,
[American Type Culture Collection (ATCC Cat#:CRL-11421)], originally
developed by Andley et al. (1994), were previously purchased by Tom
Glaser and provided to us at passage 4. Cells were cultured in Dulbecco’s
Modified Eagle Medium (DMEM) containing 4.5 g/l D-Glucose,
L-Glutamine, and 110 mg/l Sodium Pyruvate (Life Technologies,
Cat#:11995-065), supplemented with 10% FBS (Atlanta Biologicals,
Cat#:S11150) and penicillin (100 units/ml), and grown in a humidified
incubator supplied with 5% CO2 at 37°C. Cells tested negative for
mycoplasma and Fig. 5 qPCR data authenticate their human origin. For
pharmacological treatment assays, 1.0×106 to 1.5×106 B3 cells were plated
onto a 100 mm tissue culture plate and transfected as described above. At
24 h post-transfection, cells were treated with the γ-secretase inhibitor
DAPT (APExBIO, Cat#:A8200) at a concentration of 10 µM in DMSO, or
DMSO alone in controls, for an additional 24 h before being harvested as
stated above. For epoxomicin (APExBIO, Cat#:A2606) treatments, cells
were plated on 100 mm plates in medium supplemented with different
concentrations of epoxomicin or DMSO control for 24 h before being
harvested.
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Wild-type embryonic tissue was fixed in 4% paraformaldehyde/PBS for 1 h
on ice, processed by stepwise sucrose/PBS incubation ranging from 5–15%,
and embedded in OCT, then 10 μm frozen sections were generated for
marker analyses as described in Brown et al. (1998). Transfected cells grown
on chamber slide coverslips were fixed with 4% paraformaldehyde/PBS for
10 min and permeabilized with 0.5% Triton X-100/PBS for 5 min at room
temperature. Following PBS washing, cells were blocked in 4% milk/TST
for 1 h. As with tissue sections, cells cultured in slide chambers were
antibody labeled as described in Brown et al. (1998). The primary antibodies
used were rabbit anti-HA (1:200, Santa Cruz Biotechnology, Cat#:sc-805-
discontinued; AB 631618), goat anti-Jag1 (1:250, Santa Cruz
Biotechnology, Cat#:sc-6011-discontinued; AB 649689), and rabbit anti-
Psen1 (1:100, Santa Cruz Biotechnology, Cat#:sc-7860-discontinued; AB
2170581). Slides were subsequently incubated with directly conjugated
AlexaFluor secondary antibodies (1:400, Jackson ImmunoResearch or
Thermo Fisher Scientific) or biotinylated secondary antibodies (1:500,
Jackson ImmunoResearch or Thermo Fisher Scientific) followed by
AlexaFluor conjugated streptavidin (1:500, Jackson ImmunoResearch).
Nuclear staining was performed with DAPI (1:1000 dilution of a 1 mg/ml
solution, Sigma-Aldrich, Cat#:28718-90-3).
Antibody labeled cryosections and chamber slide mounts were imaged
using a Leica DM5500 microscope, equipped with a SPEII solid state
confocal and processed using Leica LASAF and Adobe Photoshop (CS4)
software programs. All images were equivalently adjusted for brightness,
contrast and pseudo-coloring. For embryonic sections, three individuals
were analyzed, using at least two sections per individual. For subcellular
localization analyses in cultured cells, three independent transfection
experiments per isoform were analyzed.
Western blotting
E14.5 or E16.5 CD-1 mouse littermate lenses were hand dissected in cold
PBS, pooled together, and snap frozen. E14.5 individual pairs of mouse
lenses in the ADAM17 allelic series were hand dissected away from other
ocular tissues, harvested in cold PBS, snap frozen. Those of identical
genotypes were subsequently pooled just prior to lysis step. Upon thawing,
the lenses were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris pH8, 1%
NP40, 0.5% DOC, 0.1% SDS) plus cOmplete mini protease inhibitor tablet
(Sigma-Aldrich, Cat#:11836153001) for 2 h with micro stir bar agitation.
B3 cell pellets were thawed on ice in RIPA buffer, followed by sonication
with a micro-tip sonicator. All lysates were spun down at 15,800 RCF,
quantified by Bradford assay (Bio-Rad Protein Assay, Cat#:500-0006), and
25 µg (or higher amounts as indicated on particular blots) of total protein
were loaded onto NuPage 4-12% Bis-Tris gel (Invitrogen, Cat#:
NP0322BOX), electrophoresed in MES running buffer (Invitrogen, Cat#:
NP0002-02), and transferred onto 0.2 µm nitrocellulose membranes
(Invitrogen, Cat#:LC2000). Blots were blocked in 5% milk/0.1 M Tris
(pH 7.4)/0.15 M NaCl/0.1% Tween20. Protein detection was performed
with subsequent primary antibodies: mouse anti-β-actin (1:3000, Sigma-
Aldrich, Cat#:A1978; AB 476692), rat anti-HA (1:2000, Sigma-Aldrich,
Cat#:11867423001;AB 390918), goat anti-Jag1 (1:2000, Santa Cruz
Biotechnology, Cat#:sc-6011-discontinued; AB 649689), and rabbit anti-
Jag1 (1:1000, Santa Cruz Biotechnology, Cat#:sc-8303-discontinued; AB
649685). Blots were incubated with HRP-conjugated secondary antibodies
from Jackson ImmunoResearch. ECL kit (Thermo Fisher Scientific,
Cat#:34078) was used for visualization as described by manufacturer.
Signals were detected using the Konica Minolta SRX-101A medical film
processor.
RNA purification and quantitative PCR analysis
Total B3 cell RNA was isolated using the Zymo Research Quick RNA
miniprep kit (Cat#:R1055). RNA concentrations were measured with a
Qubit 3.0 Fluorometer and Molecular Probes Qubit RNA HS Assay kit
(Cat#:Q32852). 100 ng of total RNAwas reverse transcribed into cDNAvia
the Bio-Rad iScript cDNA Synthesis kit (Cat#:170-8891) and used for
qPCR analysis using Applied BioSystems Fast Sybr Green Master Mix
(Cat#:4385614) and primer sets listed in Table S1 on an Applied Biosystems
StepOnePlus machine. Relative Quantification (RQ) values were calculated
using comparative CT method (Livak and Schmittgen, 2001) with β-Actin as
a normalization control. Statistical significance was determined by one-way
ANOVA or a two-tailed Student’s t-test using Microsoft Excel 2016 Analysis
ToolPak, with P-values <0.05 significant for the datasets in which n=3
biological replicates.
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